Entity Details

Primary name IGLL1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP15814
EntryNameIGLL1_HUMAN
FullNameImmunoglobulin lambda-like polypeptide 1
TaxID9606
Evidenceevidence at protein level
Length213
SequenceStatuscomplete
DateCreated1990-04-01
DateModified2021-06-02

Ontological Relatives

GenesIGLL1

GO terms

Show/Hide Table
GOName
GO:0003823 antigen binding
GO:0005576 extracellular region
GO:0005783 endoplasmic reticulum
GO:0006910 phagocytosis, recognition
GO:0006911 phagocytosis, engulfment
GO:0006955 immune response
GO:0006958 complement activation, classical pathway
GO:0009897 external side of plasma membrane
GO:0016020 membrane
GO:0034987 immunoglobulin receptor binding
GO:0042571 immunoglobulin complex, circulating
GO:0042742 defense response to bacterium
GO:0045087 innate immune response
GO:0050853 B cell receptor signaling pathway
GO:0050871 positive regulation of B cell activation
GO:0050900 leukocyte migration

Subcellular Location

Show/Hide Table
Subcellular Location
Endoplasmic reticulum
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR003006 Immunoglobulin/major histocompatibility complex, conserved siteSiteConserved site
IPR003597 Immunoglobulin C1-setDomainDomain
IPR007110 Immunoglobulin-like domainDomainDomain
IPR013783 Immunoglobulin-like foldFamilyHomologous superfamily
IPR036179 Immunoglobulin-like domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613500 OMIMAgammaglobulinemia 2, autosomal recessive (AGM2)A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB09130 CopperDrugbanksmall molecule